Adagio Medical Holdings, Inc.
ADGM
$0.791
-$0.02-2.47%
| Weiss Ratings | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.10 | |||
| Price History | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.13% | |||
| 30-Day Total Return | -46.91% | |||
| 60-Day Total Return | -35.16% | |||
| 90-Day Total Return | -60.45% | |||
| Year to Date Total Return | -32.39% | |||
| 1-Year Total Return | -92.99% | |||
| 2-Year Total Return | -92.36% | |||
| 3-Year Total Return | -91.93% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -92.99% | |||
| 52-Week Low % Change | 8.13% | |||
| Price | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.57 | |||
| 52-Week Low Price | $0.75 | |||
| 52-Week Low Price (Date) | Jan 21, 2025 | |||
| 52-Week High Price (Date) | Jul 17, 2024 | |||
| Valuation | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 12.47M | |||
| Enterprise Value | 8.15M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -20.34 | |||
| Earnings Per Share Growth | -58.47% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 20.64 | |||
| Price/Book (Q) | 0.62 | |||
| Enterprise Value/Revenue (TTM) | 13.54 | |||
| Price | $0.79 | |||
| Enterprise Value/EBITDA (TTM) | -0.24 | |||
| Enterprise Value/EBIT | -0.23 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 15.32M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 949-348-1188 | |||
| Address | 26051 Merit Circle Laguna Hills, CA 92653 | |||
| Website | adagiomedical.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -5,806.97% | |||
| Profit Margin | -12,465.28% | |||
| Management Effectiveness | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -79.06% | |||
| Return on Equity | -- | |||
| Income Statement | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 602.00K | |||
| Total Revenue (TTM) | 602.00K | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | -2.72M | |||
| EBITDA (TTM) | -33.57M | |||
| EBIT (TTM) | -34.96M | |||
| Net Income (TTM) | -75.04M | |||
| Net Income Avl. to Common (TTM) | -75.04M | |||
| Total Revenue Growth (Q YOY) | 75.64% | |||
| Earnings Growth (Q YOY) | -565.46% | |||
| EPS Diluted (TTM) | -20.34 | |||
| EPS Diluted Growth (Q YOY) | 66.95% | |||
| Balance Sheet | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.59M | |||
| Cash Per Share (Q) | $1.34 | |||
| Total Current Assets (Q) | 25.35M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 19.91M | |||
| Current Ratio (Q) | 3.265 | |||
| Book Value Per Share (Q) | $1.31 | |||
| Total Assets (Q) | 48.45M | |||
| Total Current Liabilities (Q) | 7.76M | |||
| Total Debt (Q) | 16.27M | |||
| Total Liabilities (Q) | 28.54M | |||
| Total Common Equity (Q) | 19.91M | |||
| Cash Flow | ADGM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.65M | |||
| Cash from Financing (TTM) | 15.63M | |||
| Net Change in Cash (TTM) | -15.27M | |||
| Levered Free Cash Flow (TTM) | -22.41M | |||
| Cash from Operations (TTM) | -29.46M | |||
